Literature DB >> 17934860

Mcp-1, eNOS, tPA and PAI-1 gene polymorphism and correlation of genotypes and phenotypes in hepatopulmonary syndrome.

Gokhan Tumgor1, Afig Berdeli, Cigdem Arikan, Ertürk Levent, Sema Aydogdu.   

Abstract

AIM: The aim of this case-control study was to investigate both the distribution of MCP-1, eNOS, tPA and PAI-1 gene polymorphism and correlation of genotypes and phenotypes.
METHOD: Between September 1997-January 2005, 20 patients with HPS (group 1) were compared with a group of cirrhotic patients (group 2, n = 19) as well as unrelated healthy controls (group 3, n = 59) in respect to MCP1, eNOS, tPA and PAI-1 gene polymorphism frequency distribution.
RESULTS: MCP1-2518G allele carriage in patients with HPS was higher than in controls (P = 0.01). In non-HPS cirrhotic patients, eNOS Glu298Asp, Asp gene carriers and frequency of Asp alleles were detected to be considerably higher than in patients with HPS and healthy controls (P < 0.05).
CONCLUSION: HPS is more common in patients with MCP-1 2518G gene carriage; conversely it is less frequent in patients with high frequency of eNOS 298Asp allele and eNOS 298Asp carriage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17934860     DOI: 10.1007/s10620-007-0002-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  44 in total

1.  The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis.

Authors:  L Iacoviello; F Burzotta; A Di Castelnuovo; F Zito; R Marchioli; M B Donati
Journal:  Thromb Haemost       Date:  1998-12       Impact factor: 5.249

2.  Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas.

Authors:  M J Krowka
Journal:  Hepatology       Date:  1997-05       Impact factor: 17.425

3.  MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus.

Authors:  F Aguilar; M F González-Escribano; J Sánchez-Román; A Núñez-Roldán
Journal:  Tissue Antigens       Date:  2001-11

Review 4.  PAI-1, obesity, insulin resistance and risk of cardiovascular events.

Authors:  I Juhan-Vague; M C Alessi
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

5.  Alu sequences in the coding regions of mRNA: a source of protein variability.

Authors:  W Makałowski; G A Mitchell; D Labuda
Journal:  Trends Genet       Date:  1994-06       Impact factor: 11.639

6.  A Monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation.

Authors:  Bernd Krüger; Bernd Schröppel; Rami Ashkan; Brad Marder; Carl Zülke; Barbara Murphy; Bernhard K Krämer; Michael Fischereder
Journal:  J Am Soc Nephrol       Date:  2002-10       Impact factor: 10.121

7.  Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue.

Authors:  M J Krowka; E R Dickson; D A Cortese
Journal:  Chest       Date:  1993-08       Impact factor: 9.410

8.  Nitric oxide synthase and heme oxygenase expressions in human liver cirrhosis.

Authors:  Beatrice J Goh; Bee Tee Tan; Wei Min Hon; Kang Hoe Lee; Hoon Eng Khoo
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

9.  Alu-repeat polymorphism in the tissue-type plasminogen activator (tPA) gene does not affect basal endothelial tPA synthesis.

Authors:  Y van den Eijnden-Schrauwen; N Lakenberg; J J Emeis; P de Knijff
Journal:  Thromb Haemost       Date:  1995-10       Impact factor: 5.249

10.  Hepatopulmonary syndrome induced by common bile duct ligation in a rabbit model: correlation between pulmonary vascular dilatation on thin-section CT and angiography and serum nitrite concentration or endothelial nitric oxide synthase (eNOS)1 expression.

Authors:  Ki-Nam Lee; Seong Kuk Yoon; Jin Wha Lee; Ki Nam Kim; Byung-Ho Park; Jong Young Kwak; Jin Sook Jeong; Young Hoon Kim
Journal:  Korean J Radiol       Date:  2004 Jul-Sep       Impact factor: 3.500

View more
  5 in total

Review 1.  Hepatopulmonary syndrome: What we know and what we would like to know.

Authors:  Israel Grilo-Bensusan; Juan Manuel Pascasio-Acevedo
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion.

Authors:  Thenappan Thenappan; Ankush Goel; Glenn Marsboom; Yong-Hu Fang; Peter T Toth; Hannah J Zhang; Hidemi Kajimoto; Zhigang Hong; Jonathan Paul; Christian Wietholt; Jennifer Pogoriler; Lin Piao; Jalees Rehman; Stephen L Archer
Journal:  Am J Respir Crit Care Med       Date:  2010-12-10       Impact factor: 21.405

Review 3.  Cirrhosis and hepatopulmonary syndrome.

Authors:  Gokhan Tumgor
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

4.  Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot study.

Authors:  Nuria Mendoza; Eva Rivas; Roberto Rodriguez-Roisin; Tamara Garcia; Miquel Bruguera; Alvar Agusti; Rosa Faner
Journal:  PLoS One       Date:  2021-02-25       Impact factor: 3.240

5.  Role of pulmonary intravascular macrophages in endotoxin-induced lung inflammation and mortality in a rat model.

Authors:  Sukhjit S Gill; Sarabjeet S Suri; Kyathanahalli S Janardhan; Sarah Caldwell; Tanya Duke; Baljit Singh
Journal:  Respir Res       Date:  2008-10-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.